Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Preoperative Exercise × Gynecologic × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Gynecologic Cancer 1

Interventions

Paclitaxel 68 Carboplatin 65 Cisplatin 62 Bevacizumab 25 Radiotherapy 24 Brachytherapy 20 olaparib 18 Drug Therapy 18 apatinib 15 Gemcitabine 15 niraparib 14 pembrolizumab 13 Hyperthermic Intraperitoneal Chemotherapy 13 liposomal doxorubicin 11 Surgical Procedures, Operative 11 Cyclophosphamide 11 Etoposide 9 fludarabine 8 Taxes 8 Surveys and Questionnaires 8 Blood Specimen Collection 8 camrelizumab 7 anlotinib 7 Topotecan 7 durvalumab 6 Radiotherapy, Intensity-Modulated 6 Platinum 6 Neoadjuvant Therapy 6 Albumin-Bound Paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡